Is Cingulate Stock a Good Investment?

Cingulate Investment Advice

  CING
To provide specific investment advice or recommendations on Cingulate stock, we recommend investors consider the following general factors when evaluating Cingulate. This will help you to make an informed decision on whether to include Cingulate in one of your diversified portfolios:
  • Examine Cingulate's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Cingulate's leadership team and their track record. Good management can help Cingulate navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Biotechnology space and any emerging trends that could impact Cingulate's business and its evolving consumer preferences.
  • Compare Cingulate's performance and market position to its competitors. Analyze how Cingulate is positioned in terms of product offerings, innovation, and market share.
  • Check if Cingulate pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Cingulate's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Cingulate stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Cingulate is a good investment.
 
Sell
 
Buy
Strong Sell
We provide trade advice to complement the prevailing expert consensus on Cingulate. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Cingulate is not overpriced, please confirm all Cingulate fundamentals, including its ebitda, cash flow from operations, retained earnings, as well as the relationship between the total debt and number of employees . Given that Cingulate has a price to book of 4.10 X, we suggest you to validate Cingulate market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Market Performance

OKDetails

Volatility

Somewhat reliableDetails

Hype Condition

Over hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

HighDetails

Economic Sensitivity

Follows the market closelyDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine Cingulate Stock

Researching Cingulate's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The book value of the company was currently reported as 1.55. The company recorded a loss per share of 4.03. Cingulate had not issued any dividends in recent years. The entity had 1:12 split on the 9th of August 2024.
To determine if Cingulate is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Cingulate's research are outlined below:
Cingulate appears to be risky and price may revert if volatility continues
Cingulate has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (15.55 M) with loss before overhead, payroll, taxes, and interest of (9.86 M).
Cingulate currently holds about 8.2 M in cash with (18.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Cingulate has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: What analysts say about Cingulate Inc. stock - Tremendous portfolio expansion - Autocar Professional
Cingulate uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Cingulate. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cingulate's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
8th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact Cingulate's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Cingulate's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-03-10
2022-12-31-0.37-0.41-0.0410 
2023-11-13
2023-09-30-0.37-0.30.0718 
2022-03-10
2021-12-31-0.39-0.320.0717 
2025-05-08
2025-03-31-0.94-1.04-0.110 
2022-05-12
2022-03-31-0.23-0.44-0.2191 
2023-08-14
2023-06-30-0.35-0.57-0.2262 
2022-08-11
2022-06-30-0.58-0.360.2237 
2024-11-11
2024-09-30-2.22-1.830.3917 

Cingulate Target Price Consensus

Cingulate target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Cingulate's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   4  Strong Buy
Most Cingulate analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Cingulate stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Cingulate, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Cingulate Target Price Projection

Cingulate's current and average target prices are 5.57 and 29.00, respectively. The current price of Cingulate is the price at which Cingulate is currently trading. On the other hand, Cingulate's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Cingulate Market Quote on 24th of July 2025

Low Price5.57Odds
High Price5.57Odds

5.57

Target Price

Analyst Consensus On Cingulate Target Price

Low Estimate26.39Odds
High Estimate32.19Odds

29.0

Historical Lowest Forecast  26.39 Target Price  29.0 Highest Forecast  32.19
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Cingulate and the information provided on this page.

Cingulate Analyst Ratings

Cingulate's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Cingulate stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Cingulate's financials, market performance, and future outlook by experienced professionals. Cingulate's historical ratings below, therefore, can serve as a valuable tool for investors.

Know Cingulate's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Cingulate is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cingulate backward and forwards among themselves. Cingulate's institutional investor refers to the entity that pools money to purchase Cingulate's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Citigroup Inc2025-03-31
0.0
Headlands Technologies Llc2024-12-31
0.0
Commonwealth Equity Services Inc2025-03-31
55.5 K
Geode Capital Management, Llc2025-03-31
30.4 K
Ubs Group Ag2025-03-31
22.1 K
Vanguard Group Inc2025-03-31
10.8 K
Alphamark Advisors, Llc2024-12-31
K
Bank Of America Corp2025-03-31
K
Tower Research Capital Llc2025-03-31
433
Sbi Securities Co Ltd2025-03-31
362
Advisor Group Holdings, Inc.2025-03-31
42.0
Note, although Cingulate's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Cingulate's market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.33 M.

Market Cap

15.03 Million

Cingulate's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets(1.05)(1.10)
Return On Capital Employed(1.58)(1.66)
Return On Assets(1.05)(1.10)
Return On Equity(2.09)(2.19)
Determining Cingulate's profitability involves analyzing its financial statements and using various financial metrics to determine if Cingulate is a good buy. For example, gross profit margin measures Cingulate's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Cingulate's profitability and make more informed investment decisions.

Evaluate Cingulate's management efficiency

Cingulate has return on total asset (ROA) of (1.1414) % which means that it has lost $1.1414 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.5806) %, meaning that it created substantial loss on money invested by shareholders. Cingulate's management efficiency ratios could be used to measure how well Cingulate manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1.1. The current Return On Capital Employed is estimated to decrease to -1.66. At this time, Cingulate's Non Current Assets Total are most likely to decrease significantly in the upcoming years. The Cingulate's current Non Currrent Assets Other is estimated to increase to about 18.3 B, while Total Assets are projected to decrease to roughly 11.7 M.
Last ReportedProjected for Next Year
Book Value Per Share 1.96  3.26 
Tangible Book Value Per Share 1.96  3.26 
Enterprise Value Over EBITDA(0.75)(0.78)
Price Book Value Ratio 2.52  2.39 
Enterprise Value Multiple(0.75)(0.78)
Price Fair Value 2.52  2.39 
Enterprise Value10.5 M9.3 M
Leadership effectiveness at Cingulate is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Beta
(0.80)

Basic technical analysis of Cingulate Stock

As of the 24th of July, Cingulate shows the Mean Deviation of 3.19, downside deviation of 3.94, and Risk Adjusted Performance of 0.1137. Cingulate technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cingulate jensen alpha, as well as the relationship between the potential upside and skewness to decide if Cingulate is priced correctly, providing market reflects its regular price of 5.57 per share. Given that Cingulate has jensen alpha of 0.3707, we suggest you to validate Cingulate's prevailing market performance to make sure the company can sustain itself at a future point.

Cingulate's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cingulate insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cingulate's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cingulate insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Cingulate's Outstanding Corporate Bonds

Cingulate issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cingulate uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cingulate bonds can be classified according to their maturity, which is the date when Cingulate has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand Cingulate's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Cingulate's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Cingulate's intraday indicators

Cingulate intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cingulate stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Cingulate Corporate Filings

8K
22nd of July 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F3
10th of July 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
F4
9th of July 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
28th of April 2025
Other Reports
ViewVerify
Cingulate time-series forecasting models is one of many Cingulate's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cingulate's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Cingulate Stock media impact

There is far too much social signal, news, headlines, and media speculation about Cingulate that are available to investors today. This information is accessible both publicly - through Cingulate's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Cingulate-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Cingulate news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cingulate relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cingulate's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cingulate alpha.

Cingulate Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Cingulate can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Cingulate Corporate Executives

Elected by the shareholders, the Cingulate's board of directors comprises two types of representatives: Cingulate inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cingulate. The board's role is to monitor Cingulate's management team and ensure that shareholders' interests are well served. Cingulate's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cingulate's outside directors are responsible for providing unbiased perspectives on the board's policies.
Raul MDExecutive CoFounderProfile
Matthew MDExecutive CoFounderProfile
Jennifer CPASenior CFOProfile
Dr MBAExecutive COOProfile
When determining whether Cingulate is a strong investment it is important to analyze Cingulate's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cingulate's future performance. For an informed investment choice regarding Cingulate Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cingulate. If investors know Cingulate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cingulate listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.03)
Return On Assets
(1.14)
Return On Equity
(3.58)
The market value of Cingulate is measured differently than its book value, which is the value of Cingulate that is recorded on the company's balance sheet. Investors also form their own opinion of Cingulate's value that differs from its market value or its book value, called intrinsic value, which is Cingulate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cingulate's market value can be influenced by many factors that don't directly affect Cingulate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Cingulate's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Cingulate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cingulate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.